Amir ShiraliZadeh Dezfuli, CEO of Ronash Technology Pars Company announces that high-quality DNA and RNA extraction kits are available at a fraction of the European prices, crucial for detecting disease-causing viruses like HIV and influenza.
Amir Shiralizadeh Dezfuli, CEO of this company, says: "The DNA and RNA extraction kits produced in this company, despite their very high quality, have a much lower price than the European, Taiwanese, and Chinese kits.
Amir ShiraliZadeh Dezfuli, CEO of Ronash Technology Pars Company announces that high-quality DNA and RNA extraction kits are available at a fraction of the European prices, crucial for detecting disease-causing viruses like HIV and influenza.
He also announced the expansion of their product line to include DNA extraction technology alongside RNA kits. With a production capacity of 500 reactions per day, scaling to 5000 during peak periods like the COVID-19 pandemic, these kits are crucial for diagnostics in hospitals and research centers. Additionally, ongoing research into magnetic particle-based cell separation technology shows promise for cancer diagnosis and treatment. Plans for educational nanokits targeting various age groups were also revealed.
Ronash Technology Pars Company, an Iranian knowledge-based company, focuses on the development and production of products based on nanoscience. All activities and projects of the company are centered around advanced materials and nanomaterials, developing products based on nanotechnology, as well as producing and developing products based on biotechnology.